Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 8 studies | 22% ± 3% | |
| brain | 7 studies | 36% ± 10% | |
| lung | 6 studies | 23% ± 9% | |
| kidney | 6 studies | 20% ± 3% | |
| intestine | 4 studies | 27% ± 14% | |
| liver | 4 studies | 32% ± 16% | |
| pancreas | 3 studies | 34% ± 6% | |
| lymph node | 3 studies | 26% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2429.97 | 1445 / 1445 | 100% | 19.76 | 183 / 183 |
| ovary | 100% | 1591.70 | 180 / 180 | 100% | 13.42 | 430 / 430 |
| breast | 100% | 2158.04 | 459 / 459 | 100% | 16.93 | 1117 / 1118 |
| lung | 100% | 2434.43 | 577 / 578 | 100% | 17.63 | 1155 / 1155 |
| brain | 100% | 1966.58 | 2635 / 2642 | 100% | 18.41 | 705 / 705 |
| prostate | 100% | 1905.68 | 244 / 245 | 100% | 19.02 | 502 / 502 |
| thymus | 100% | 2418.31 | 653 / 653 | 100% | 18.07 | 602 / 605 |
| intestine | 100% | 1992.91 | 966 / 966 | 99% | 15.38 | 524 / 527 |
| stomach | 100% | 1604.78 | 359 / 359 | 99% | 15.75 | 284 / 286 |
| uterus | 100% | 1803.68 | 170 / 170 | 99% | 12.02 | 454 / 459 |
| bladder | 100% | 2097.05 | 21 / 21 | 99% | 12.93 | 498 / 504 |
| kidney | 100% | 2039.37 | 89 / 89 | 99% | 17.73 | 889 / 901 |
| adrenal gland | 100% | 2834.93 | 258 / 258 | 97% | 10.19 | 223 / 230 |
| pancreas | 98% | 1017.02 | 321 / 328 | 99% | 11.34 | 176 / 178 |
| liver | 100% | 1214.09 | 226 / 226 | 95% | 8.11 | 385 / 406 |
| skin | 100% | 3815.53 | 1809 / 1809 | 91% | 12.03 | 431 / 472 |
| adipose | 100% | 2415.30 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3148.63 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 11.76 | 29 / 29 |
| muscle | 100% | 2947.08 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1569.82 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 12.76 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.89 | 1 / 1 |
| heart | 96% | 2727.82 | 825 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 69% | 5.59 | 55 / 80 |
| peripheral blood | 54% | 1399.38 | 502 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1903292 | Biological process | protein localization to Golgi membrane |
| GO_0016192 | Biological process | vesicle-mediated transport |
| GO_0006886 | Biological process | intracellular protein transport |
| GO_0005802 | Cellular component | trans-Golgi network |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005525 | Molecular function | GTP binding |
| GO_0003924 | Molecular function | GTPase activity |
| Gene name | ARL5A |
| Protein name | ADP-ribosylation factor-like protein 5A ADP ribosylation factor like GTPase 5A |
| Synonyms | ARL5 ARFLP5 |
| Description | FUNCTION: Lacks ADP-ribosylation enhancing activity. . |
| Accessions | F8WER2 ENST00000295087.13 [Q9Y689-1] ENST00000428992.2 [Q9Y689-2] Q9Y689 ENST00000458140.6 ENST00000446896.7 [Q9Y689-2] |